ViveBiotech S.L.

https://www.vivebiotech.com

LinkedIn: https://www.linkedin.com/company/vivebiotech

VIVEbiotech is a company fully specialized in lentiviral vectors with expertise as a GMP CDMO focused on the manufacture of lentiviral vectors from early stages to GMP. Working with European, US-based and Asian companies, its main aim is to adapt to customer own requirements from a technical and timeline perspective. In addition, VIVEbiotech ´s technology development strategy is focused on providing a response to the main hurdles that currently exist within the gene therapy field, mainly the need of cost-effective processes and the enhancement of the safety profile of viral vectors. In this setting, VIVEbiotech has its own worldwide licensed technology, LENTISOMA. *

	Start	2015-01-01 established
	Industry	lentiviral vector
	Industry 2	Lentisoma technology
	Person	Linazasoro, Gurutz (ViveBiotech 202106 CEO)

	Region	San Sebastián
	Country	Spain (España)
	Street	170 Miramon Pasealekua Donostia
	City	20009 San Sebastián
	Tel	+34-943-308568
		Address record changed: 2024-05-03

Basic data	Employees	C: 51 to 100 (2021-12-31)

		* Document for »About Section«: ViveBiotech S.L.. (6/4/21). "Press Release: ViveBiotech Launches Lentiviral Vector Manufacturing Plant for Cell and Gene Therapy Sector".

		Record changed: 2021-06-11

Picture Berlin Partner BIO 2024 International Convention San Diego 650x200px

More documents for ViveBiotech S.L.

[1] ViveBiotech S.L.. (6/4/21). "Press Release: ViveBiotech Launches Lentiviral Vector Manufacturing Plant for Cell and Gene Therapy Sector"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]